The Therapeutic Potential of Monocyte/Macrophage Manipulation in the Treatment of Chemotherapy-Induced Painful Neuropathy
In cancer treatments a dose-limiting side-effect of chemotherapeutic agents is the development of neuropathic pain, which is poorly managed by clinically available drugs at present. Chemotherapy-induced painful neuropathy (CIPN) is a major cause of premature cessation of treatment and so a greater u...
Main Authors: | Karli Montague, Marzia Malcangio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-11-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fnmol.2017.00397/full |
Similar Items
-
A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy
by: Yusuke Fukuda, et al.
Published: (2017-08-01) -
A novel interaction between CX3CR1 and CCR2 signalling in monocytes constitutes an underlying mechanism for persistent vincristine-induced pain
by: Karli Montague, et al.
Published: (2018-04-01) -
Flavonoids Alleviate Peripheral Neuropathy Induced by Anticancer Drugs
by: Manaal Siddiqui, et al.
Published: (2021-03-01) -
Quantitative sensory profiles of upper extremity chemotherapy induced peripheral neuropathy: Are there differences in sensory profiles for neuropathic versus nociceptive pain?
by: Elizabeth Andersen Hammond, et al.
Published: (2019-01-01) -
A review of movement disorders in chemotherapy-induced neurotoxicity
by: Allison B. Wang, et al.
Published: (2021-01-01)